Equibles does not estimate personal net worth.
Get an email with a short summary when Eupraxia Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get EPRX alertsJames Halliwell is recorded as CEO at Eupraxia Pharmaceuticals Inc. (EPRX). James Halliwell has spoken on 3 investor events across 1 company, most recently for Eupraxia Pharmaceuticals Inc. on October 22, 2026. Eupraxia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector.
“First, Albert, thank you very much to you and to Craig Hallam for having us today. It's a real privilege to be here. So EOE is a really interesting disease. And in some ways, it's sort of come out of nowhere all of a sudden.”
“I'm the CEO and co-founder of Upraxy Pharmaceuticals. Really appreciate everybody here in person and those who are listening not live with us here. So really appreciate you taking the time.”
“I'm gonna walk you through the Upraxia story today and we also excitingly have a little bit of fresh data that came out this morning.”
Biotechnology · Healthcare
CEO
